(Q80473371)

English

Oxaliplatin/fluorouracil/leucovorin (FOLFOX4 and modified FOLFOX6) in patients with refractory or advanced colorectal cancer: post-approval Japanese population experience

scientific article published on 27 June 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17566846%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Oxaliplatin/fluorouracil/leucovorin (FOLFOX4 and modified FOLFOX6) in patients with refractory or advanced colorectal cancer: post-approval Japanese population experience (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17566846%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

colorectal cancer

1 reference

based on heuristic

inferred from title

3

object named as

Kenji Tamura

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17566846%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Toshio Shimizu

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17566846%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Taroh Satoh

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17566846%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Tomohiro Ozaki

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17566846%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Isamu Okamoto

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17566846%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Masahiro Fukuoka

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17566846%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Kazuhiko Nakagawa

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17566846%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

27 June 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17566846%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

International Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17566846%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17566846%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17566846%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

218-223

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17566846%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

https://scigraph.springernature.com/pub.10.1007/s10147-007-0658-x

0 references

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17566846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17566846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17566846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxaliplatin as single agent in previously untreated colorectal carcinoma patients: A phase II multicentric study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17566846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate

1 reference

https://pubmed.ncbi.nlm.nih.gov/17566846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modified de Gramont with oxaliplatin in the first-line treatment of advanced colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17566846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17566846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines

1 reference

https://pubmed.ncbi.nlm.nih.gov/17566846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17566846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17566846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17566846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17566846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17566846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17566846

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10147-007-0658-X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17566846%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17566846%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80473371&oldid=1822347530"